artemether-lumefantrine (AL)

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

MalariaPlasmodium Falciparum MalariaMalaria, Falciparum

79 competitors in Malaria

#DrugCompanyPhaseTrials

1

Stromectol

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Approved

72

Dihydroartemisinin-Piperaquine

GSK

Phase 3

513

Rabies Vaccine

Novartis

Phase 3

84

Krintafel

GGlaxo Dba Glaxosmithkline

Phase 3

35

artemether-lumefantrine (AL)

Novartis

Phase 3

116

Artesunate-Amodiaquine

Sanofi

Phase 3

197

R21/matrix-M

UUniversity of Oxford

Phase 3

48

Pyramax

SShin Poong Pharmaceutical Co. Ltd.

Phase 3

29

Biltricide

Bayer

Preclinical

110

Stelara

Johnson & Johnson

Preclinical

—Show 16 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Malaria11 trials

Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children

Completed·IInstitute of Tropical Medicine, Belgium·Phase 3·NCT00393679·4,112 enrolled

Impact of Malaria Mass Drug Administration on Malaria Prevalence in Under 15 Children and Pregnant Women

Completed·NNoguchi Memorial Institute for Medical Research·N/A·NCT07358767·3,300 enrolled

Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Uncomplicated Malaria in South Kivu, DR Congo

Completed·MMedecins Sans Frontieres, Netherlands·Phase 4·NCT02741024·288 enrolled

Show 8 more trials

A Study to Find Out if a Combination of 3 Medicines for the Treatment of Malaria Works as Well and is as Safe and Tolerable as Combinations of 2 Medicines

Recruiting·UUniversity of Oxford·Phase 3·NCT05951595·1,680 enrolled

OPTImizing Malaria And HIV Treatment in a Shifting Landscape in Africa

Recruiting·YYale University·Phase 4·NCT06967519·380 enrolled

Interactions Between Artemether-lumefantrine and Antiretrovirals in HIV-patients With Uncomplicated Malaria in Tanzania

Completed·UUniversity of Copenhagen·Phase 4·NCT00885287·830 enrolled

In Vivo Efficacy of Artemether-Lumefantrine and Artesunate-Amodiaquine for Uncomplicated P. Falciparum Malaria

Completed·CCenters for Disease Control and Prevention·Phase 4·NCT02637128·452 enrolled

Effectiveness and Safety of Artemether + Lumefantrine and Dihydroartemisinin + Piperaquine for Treating Malaria

Completed·BBandim Health Project·Phase 4·NCT04897919·474 enrolled

Study in Blood Stage Malaria Infection After DVI of Cryopreserved P. Falciparum (NF54 Strain) Sporozoites

Completed·Medicines for Malaria Venture·Phase 1·NCT04310085·16 enrolled

Efficacy, Safety and Pharmacokinetics of Artemether-lumefantrine Dispersible Tablet in the Treatment of Malaria in Infants < 5 kg

Completed·Novartis·Phase 2/3·NCT01619878·20 enrolled

Malaria Therapeutic Efficacy Study, Rwanda

Completed·JJhpiego·Phase 4·NCT04767217·528 enrolled

Efficacy1 trial

Therapeutic Efficacy Study of AL and DP in Western Kenya

Completed·KKenya Medical Research Institute·N/A·NCT05060198·340 enrolled

COVID-191 trial

Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso

Completed·LLiverpool School of Tropical Medicine·Phase 3·NCT04695197·143 enrolled

Plasmodium Falciparum1 trial

Chloroquine and Coartem for Treatment of Symptomatic Children With Plasmodium Falciparum in Guinea Bissau

Completed·BBandim Health Project·Phase 4·NCT00426439·300 enrolled

Plasmodium falciparum malaria1 trial

Efficacy of Artemether-Lumefantrine in the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Children Under 12 Years at Four Sentinel Sites in Mozambique

Completed·CCentro de Investigacao em Saude de Manhica·N/A·NCT06970600·352 enrolled

Details

Drug Info

Related News